The 2026 AHA/ASA guidelines for acute ischemic stroke introduce significant updates and first-ever pediatric stroke recommendations.
The guidelines for care of patients that have experienced acute ischemic stroke have been updated by the American Stroke Association.
The "golden window" for treatment was strictly limited to 4.5 hours. However, the 2026 guidelines introduce a more flexible approach based on advanced imaging.
Findings from the ASA International Stroke Conference show tenecteplase 4.5 to 24 hours after onset improves 90-day functional outcomes.
Global phase 3 OCEANIC-STROKE randomized 12,327 patients to asundexian 50 mg daily vs placebo on background antiplatelets, with follow-up to 31 months. Treatment effects were consistent across TOAST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results